Healthy aging during the COVID-19 pandemic
DOI:
https://doi.org/10.15448/2357-9641.2021.1.41087Palabras clave:
covid-19, Healthy agingResumen
---
Descargas
Citas
World Health Organization. WHO. Coronavirus. 2021 (May, 24 2021). Retrived from https://www.who.int/health-topics/coronavirus#tab=tab_1
Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev [Internet]. 2021;65(August 2020):101205. Available from: https://doi.org/10.1016/j.arr.2020.101205
Biswas A, Mandal RS, Chakraborty S, Maiti G. Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population. Int Rev Immunol [Internet]. 2021;0(0):1–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33978550
Margarete Diprat Trevisan Patricia Morsch, Lopes DGC, Oliveira GG de, Bós ÂJG. Association between quality of life and activities developed by older adults from the Rio Grande do Sul state. Pajar. 2017;5(2):47–54.
Nehme J, Borghesan M, Mackedenski S, Bird TG, Demaria M. Cellular senescence as a potential mediator of COVID-19 severity in the elderly. Aging Cell. 2020;19(10):1–14.
Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38(2):337–42.
McGonagle D, Sharif K, O’Regan A, Bridgewood C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020;19(6).
Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;11(January):1–23.
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146(1):89–100.
Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immuno-aging on SARS-CoV-2 vaccine development. GeroScience. 2021;(March 2020):31–51.
Tenforde MW, Olson SM, Self WH, Talbot HK, Lindsell CJ, Steingrub JS, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep [Internet]. 2021;70(18):674–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33956782
Lisa Müller, Marcel Andrée, Wiebke Moskorz, Ingo Drexler, Lara Walotka, Ramona Grothmann, Johannes Ptok, Jonas Hillebrandt, Anastasia Ritchie, Denise Rabl, Philipp Niklas Ostermann, Rebekka Robitzsch, Sandra Hauka, Andreas Walker, Christopher Menne, Ralf HS. Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination. medRxiv [Internet]. 2021;2021.03.03.21251066. Available from: https://www.medrxiv.org/content/10.1101/2021.03.03.21251066v1
Victora CG, Castro MC, Gurzenda S, Barros AJD. Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality. medRxiv [Internet]. 2021;2021.04.27.21256187. Available from: http://medrxiv.org/content/early/2021/04/30/2021.04.27.21256187.abstract
Woods JA, Keylock KT, Lowder T, Vieira VJ, Zelkovich W, Dumich S, et al. Cardiovascular exercise training extends influenza vaccine seroprotection in sedentary older adults: The immune function intervention trial. J Am Geriatr Soc. 2009;57(12):2183–91.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2021 PAJAR - Pan-American Journal of Aging Research
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Derechos de Autor
La sumisión de originales para la PAJAR implica la transferencia, por los autores, de los derechos de publicación. El copyright de los artículos de esta revista es el autor, junto con los derechos de la revista a la primera publicación. Los autores sólo podrán utilizar los mismos resultados en otras publicaciones indicando claramente a PAJAR como el medio de la publicación original.
Creative Commons License
Excepto donde especificado de modo diferente, se aplican a la materia publicada en este periódico los términos de una licencia Creative Commons Atribución 4.0 Internacional, que permite el uso irrestricto, la distribución y la reproducción en cualquier medio siempre y cuando la publicación original sea correctamente citada.